Tn and sialyl-Tn antigens, aberrant O-glycomics as human disease markers. 2013

Tongzhong Ju, and Yingchun Wang, and Rajindra P Aryal, and Sylvain D Lehoux, and Xiaokun Ding, and Matthew R Kudelka, and Christopher Cutler, and Junwei Zeng, and Jianmei Wang, and Xiaodong Sun, and Jamie Heimburg-Molinaro, and David F Smith, and Richard D Cummings
Department of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA.

In many different human disorders, the cellular glycome is altered. An interesting but poorly understood alteration occurs in the mucin-type O-glycome, in which there is aberrant expression of the truncated O-glycans Tn (GalNAcα1-Ser/Thr) and its sialylated version sialyl-Tn (STn) (Neu5Acα2,6GalNAcα1-Ser/Thr). Both Tn and STn are tumor-associated carbohydrate antigens and tumor biomarkers, since they are not expressed normally and appear early in tumorigenesis. Moreover, their expression is strongly associated with poor prognosis and tumor metastasis. The Tn and STn antigens are also expressed in other human diseases and disorders, such as Tn syndrome and IgA nephropathy. The major pathological mechanism for expression of the Tn and STn antigens is compromised T-synthase activity, resulting from alteration of the X-linked gene that encodes for Cosmc, a molecular chaperone specifically required for the correct folding of T-synthase to form active enzyme. This review will summarize our current understanding of the Tn and STn antigens in terms of their biochemistry and role in pathology.

UI MeSH Term Description Entries
D009077 Mucins High molecular weight mucoproteins that protect the surface of EPITHELIAL CELLS by providing a barrier to particulate matter and microorganisms. Membrane-anchored mucins may have additional roles concerned with protein interactions at the cell surface. Mucin
D004194 Disease A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown. Diseases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers
D015295 Antigens, Tumor-Associated, Carbohydrate Carbohydrate antigens expressed by malignant tissue. They are useful as tumor markers and are measured in the serum by means of a radioimmunoassay employing monoclonal antibodies. Antigens, Carbohydrate, Tumor-Associated,CA Antigens,Cancer-Associated Carbohydrate Antigens,Carbohydrate Antigens, Tumor-Associated,Tumor-Associated Carbohydrate Antigens,Antigen, Carcinoma-Associated,CA Antigen,CA(Oxford) Antigen,Carcinoma-Associated Antigen,Epitectin,Antigen, CA,Antigen, Carcinoma Associated,Antigens, CA,Antigens, Cancer-Associated Carbohydrate,Antigens, Tumor-Associated Carbohydrate,Cancer Associated Carbohydrate Antigens,Carbohydrate Antigens, Cancer-Associated,Carbohydrate Antigens, Tumor Associated,Carcinoma Associated Antigen,Tumor Associated Carbohydrate Antigens
D054794 Glycomics The systematic study of the structure and function of the complete set of glycans (the glycome) produced in a single organism and identification of all the genes that encode glycoproteins. Sugar Code,Glycobiology

Related Publications

Tongzhong Ju, and Yingchun Wang, and Rajindra P Aryal, and Sylvain D Lehoux, and Xiaokun Ding, and Matthew R Kudelka, and Christopher Cutler, and Junwei Zeng, and Jianmei Wang, and Xiaodong Sun, and Jamie Heimburg-Molinaro, and David F Smith, and Richard D Cummings
January 1996, Gynecologic and obstetric investigation,
Tongzhong Ju, and Yingchun Wang, and Rajindra P Aryal, and Sylvain D Lehoux, and Xiaokun Ding, and Matthew R Kudelka, and Christopher Cutler, and Junwei Zeng, and Jianmei Wang, and Xiaodong Sun, and Jamie Heimburg-Molinaro, and David F Smith, and Richard D Cummings
December 2020, Veterinary and comparative oncology,
Tongzhong Ju, and Yingchun Wang, and Rajindra P Aryal, and Sylvain D Lehoux, and Xiaokun Ding, and Matthew R Kudelka, and Christopher Cutler, and Junwei Zeng, and Jianmei Wang, and Xiaodong Sun, and Jamie Heimburg-Molinaro, and David F Smith, and Richard D Cummings
June 1994, Glycoconjugate journal,
Tongzhong Ju, and Yingchun Wang, and Rajindra P Aryal, and Sylvain D Lehoux, and Xiaokun Ding, and Matthew R Kudelka, and Christopher Cutler, and Junwei Zeng, and Jianmei Wang, and Xiaodong Sun, and Jamie Heimburg-Molinaro, and David F Smith, and Richard D Cummings
August 2015, Biomolecules,
Tongzhong Ju, and Yingchun Wang, and Rajindra P Aryal, and Sylvain D Lehoux, and Xiaokun Ding, and Matthew R Kudelka, and Christopher Cutler, and Junwei Zeng, and Jianmei Wang, and Xiaodong Sun, and Jamie Heimburg-Molinaro, and David F Smith, and Richard D Cummings
January 2001, Cancer detection and prevention,
Tongzhong Ju, and Yingchun Wang, and Rajindra P Aryal, and Sylvain D Lehoux, and Xiaokun Ding, and Matthew R Kudelka, and Christopher Cutler, and Junwei Zeng, and Jianmei Wang, and Xiaodong Sun, and Jamie Heimburg-Molinaro, and David F Smith, and Richard D Cummings
October 2020, ACS infectious diseases,
Tongzhong Ju, and Yingchun Wang, and Rajindra P Aryal, and Sylvain D Lehoux, and Xiaokun Ding, and Matthew R Kudelka, and Christopher Cutler, and Junwei Zeng, and Jianmei Wang, and Xiaodong Sun, and Jamie Heimburg-Molinaro, and David F Smith, and Richard D Cummings
August 1998, Acta medica Okayama,
Tongzhong Ju, and Yingchun Wang, and Rajindra P Aryal, and Sylvain D Lehoux, and Xiaokun Ding, and Matthew R Kudelka, and Christopher Cutler, and Junwei Zeng, and Jianmei Wang, and Xiaodong Sun, and Jamie Heimburg-Molinaro, and David F Smith, and Richard D Cummings
January 2001, Anticancer research,
Tongzhong Ju, and Yingchun Wang, and Rajindra P Aryal, and Sylvain D Lehoux, and Xiaokun Ding, and Matthew R Kudelka, and Christopher Cutler, and Junwei Zeng, and Jianmei Wang, and Xiaodong Sun, and Jamie Heimburg-Molinaro, and David F Smith, and Richard D Cummings
April 1999, Pathology international,
Tongzhong Ju, and Yingchun Wang, and Rajindra P Aryal, and Sylvain D Lehoux, and Xiaokun Ding, and Matthew R Kudelka, and Christopher Cutler, and Junwei Zeng, and Jianmei Wang, and Xiaodong Sun, and Jamie Heimburg-Molinaro, and David F Smith, and Richard D Cummings
August 1997, Human pathology,
Copied contents to your clipboard!